Your browser is no longer supported. Please, upgrade your browser.
Settings
CEMI Chembio Diagnostics, Inc. daily Stock Chart
CEMI [NASD]
Chembio Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.57 Insider Own0.90% Shs Outstand12.49M Perf Week-5.19%
Market Cap91.18M Forward P/E- EPS next Y-0.11 Insider Trans15.18% Shs Float10.61M Perf Month-11.52%
Income-6.90M PEG- EPS next Q-0.10 Inst Own31.60% Short Float0.86% Perf Quarter9.77%
Sales22.30M P/S4.09 EPS this Y-404.60% Inst Trans6.13% Short Ratio2.98 Perf Half Y18.70%
Book/sh1.21 P/B6.03 EPS next Y76.10% ROA-34.50% Target Price10.00 Perf Year20.66%
Cash/sh0.15 P/C47.99 EPS next 5Y25.00% ROE-42.70% 52W Range5.05 - 9.20 Perf YTD-10.98%
Dividend- P/FCF- EPS past 5Y-30.10% ROI-77.70% 52W High-20.65% Beta1.16
Dividend %- Quick Ratio2.20 Sales past 5Y-1.60% Gross Margin46.20% 52W Low44.55% ATR0.27
Employees131 Current Ratio3.50 Sales Q/Q105.40% Oper. Margin-31.20% RSI (14)37.05 Volatility3.23% 3.31%
OptionableNo Debt/Eq0.01 EPS Q/Q75.30% Profit Margin-31.10% Rel Volume2.41 Prev Close7.20
ShortableYes LT Debt/Eq0.01 EarningsMar 06 AMC Payout- Avg Volume30.63K Price7.30
Recom2.00 SMA20-7.27% SMA50-8.91% SMA2008.01% Volume73,817 Change1.39%
Aug-11-16Reiterated The Benchmark Company Speculative Buy $10 → $9
Apr-18-16Reiterated The Benchmark Company Speculative Buy $6 → $8
Nov-04-15Initiated The Benchmark Company Speculative Buy $6
Sep-10-13Resumed The Benchmark Company Speculative Buy $7
Feb-22-18 05:59PM  Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018 GlobeNewswire
Feb-09-18 07:00AM  Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock GlobeNewswire -7.10%
Feb-08-18 05:15PM  Chembio Diagnostics Announces Proposed Public Offering of Common Stock GlobeNewswire
05:02PM  Chembio Diagnostics Announces Major New Tender Win and Certain Preliminary 2017 Financial Results GlobeNewswire
Dec-28-17 11:55AM  ETFs with exposure to Chembio Diagnostics, Inc. : December 28, 2017 Capital Cube
Dec-27-17 08:44AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-21-17 08:50AM  Chembio Diagnostics Announces Completion of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System GlobeNewswire
Dec-20-17 08:50AM  Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer GlobeNewswire
Dec-19-17 08:50AM  Chembio Diagnostics and AstraZeneca Enter a Collaboration to Develop Point-of-Care Diagnostic Test GlobeNewswire
Dec-07-17 09:00AM  CEMI: Moving PT to $15.5/Share On Upward Revenue Revisions, Comp Multiple Expansion Zacks Small Cap Research
Dec-05-17 08:50AM  Chembio Receives $8.5 Million Commitment from Bio-Manguinhos to Purchase Components for Production of DPP® Assays in Brazil during 2018 GlobeNewswire
Nov-28-17 08:50AM  Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care DPP® Zika Assays and DPP® Micro Readers GlobeNewswire
Nov-20-17 09:00AM  CEMI: DPP HIV/Syph, Several DPP Fever Products to Drive 2018 Growth Zacks Small Cap Research
Nov-09-17 12:20PM  ETFs with exposure to Chembio Diagnostics, Inc. : November 9, 2017 Capital Cube
Nov-08-17 09:03PM  Edited Transcript of CEMI earnings conference call or presentation 8-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
04:15PM  Chembio Diagnostics Reports Third Quarter 2017 Financial Results GlobeNewswire
01:00PM  CHEMBIO DIAGNOSTICS, INC. to Host Earnings Call ACCESSWIRE
Nov-07-17 04:10PM  Investor Network Invites You to the Chembio 2017 Third Quarter Earnings Conference Call and Webcast Live on Wednesday, November 8, 2017 ACCESSWIRE +6.67%
Nov-01-17 08:50AM  Chembio to Host Conference Call to Discuss Third Quarter 2017 Financial Results GlobeNewswire
Oct-30-17 11:33AM  ETFs with exposure to Chembio Diagnostics, Inc. : October 30, 2017 Capital Cube
Oct-17-17 09:37AM  ETFs with exposure to Chembio Diagnostics, Inc. : October 17, 2017 Capital Cube
Oct-05-17 10:55AM  ETFs with exposure to Chembio Diagnostics, Inc. : October 5, 2017 Capital Cube
Oct-04-17 09:25AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017 Capital Cube
Sep-28-17 08:50AM  Chembio Diagnostics Receives FDA Emergency Use Authorization for the First Rapid Zika IgM Test GlobeNewswire
Aug-17-17 05:00PM  Chembio Diagnostics Announces Retirement of Chief Financial Officer GlobeNewswire
Aug-16-17 10:25PM  Edited Transcript of CEMI earnings conference call or presentation 9-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-17 04:15PM  Chembio Diagnostics Reports Second Quarter 2017 Financial Results GlobeNewswire
12:10PM  Investor Network: CHEMBIO DIAGNOSTICS, INC. to Host Earnings Call ACCESSWIRE
Aug-08-17 04:05PM  Investor Network Invites You to the Chembio 2017 Second Quarter Earnings Conference Call and Webcast Live on Wednesday, August 9, 2017 ACCESSWIRE
Aug-03-17 08:50AM  Chembio to Host Conference Call to Discuss Second Quarter 2017 Financial Results GlobeNewswire
Jul-06-17 08:50AM  Gail S. Page Joins Chembio Diagnostics Board of Directors GlobeNewswire
Jul-05-17 08:50AM  Chembios DPP® Zika System Including the DPP® Micro Reader Approved by Brazils Health Regulatory Agency GlobeNewswire
Jun-27-17 04:30PM  Chembio Diagnostics Announces At-The-Market Program GlobeNewswire
Jun-16-17 03:33PM  ETFs with exposure to Chembio Diagnostics, Inc. : June 16, 2017 Capital Cube
Jun-14-17 09:38AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-09-17 04:20PM  Edited Transcript of CEMI earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
Jun-02-17 08:15AM  Blog Coverage Chembio Announces Major Leadership Shuffle as CEO Sperzel Takes Medical Leaves Accesswire
May-18-17 12:00PM  CEMI New Strategy Paying Dividends As Product Sales Bounce Back Zacks Small Cap Research
May-10-17 07:50AM  Edited Transcript of CEMI earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-09-17 04:10PM  Chembio Diagnostics Reports First Quarter 2017 Financial Results GlobeNewswire
01:30PM  Investor Network: CHEMBIO DIAGNOSTICS, INC. to Host Earnings Call Accesswire
May-08-17 04:05PM  Investor Network Invites You to the Chembio 2017 First Quarter Earnings Conference Call and Webcast Live on Tuesday, May 9, 2017 Accesswire
May-03-17 08:50AM  Chembio Secures $5.8 Million Bio-Manguinhos Order to Supply Components for Production of DPP® HIV 1/2 Assay in Brazil GlobeNewswire
May-02-17 08:50AM  Chembio to Host Conference Call to Discuss First Quarter 2017 Financial Results GlobeNewswire
Apr-05-17 04:29PM  ETFs with exposure to Chembio Diagnostics, Inc. : April 5, 2017 Capital Cube
Apr-04-17 08:50AM  Chembio and FIND Collaborate to Develop Point-of-Care Multiplex Test for Acute Febrile Illnesses in Asia Pacific GlobeNewswire
Mar-17-17 12:03PM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube
Mar-15-17 01:53PM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Capital Cube
Mar-11-17 01:04PM  CHEMBIO DIAGNOSTICS, INC. Financials
Mar-10-17 11:15AM  CEMI: Surprise Rebound In Lateral Flow, Expect DPP Strong Showing In 2017 Zacks Small Cap Research
Mar-07-17 04:10PM  Chembio Diagnostics Reports 2016 Financial Results GlobeNewswire
04:04PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 10-K, Annual Report
04:03PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:07AM  Q4 2016 Chembio Diagnostics Inc Earnings Release - After Market Close
Mar-06-17 04:05PM  Investor Network Invites You to the Chembio 2016 Year-End Earnings Conference Call and Webcast Live on Tuesday, March 7, 2017 Accesswire
Feb-28-17 10:00AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-27-17 08:50AM  Chembio to Host Conference Call to Discuss 2016 Financial Results GlobeNewswire
Jan-26-17 08:50AM  Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific GlobeNewswire
Jan-17-17 03:41PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:50AM  Chembios DPP® HIV-Syphilis Assay Receives CE Mark for Simultaneous Point-of-Care Detection of HIV and Syphilis GlobeNewswire
Jan-10-17 04:51PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
08:50AM  Chembio Completes Acquisition of Malaysia-based RVR Diagnostics GlobeNewswire
Jan-09-17 01:06PM  ETFs with exposure to Chembio Diagnostics, Inc. : January 9, 2017 Capital Cube
01:06PM  ETFs with exposure to Chembio Diagnostics, Inc. : January 9, 2017
Dec-30-16 10:57AM  ETFs with exposure to Chembio Diagnostics, Inc. : December 30, 2016
Dec-13-16 02:01PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-14-16 01:03PM  ETFs with exposure to Chembio Diagnostics, Inc. : November 14, 2016 Capital Cube
01:03PM  ETFs with exposure to Chembio Diagnostics, Inc. : November 14, 2016
Nov-11-16 11:24AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
Nov-10-16 08:53AM  Chembio reports 3Q loss
08:50AM  Chembio Diagnostics Reports Third Quarter 2016 Financial Results GlobeNewswire
08:25AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:20AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q3 2016 Chembio Diagnostics Inc Earnings Release - Before Market Open
Nov-09-16 04:31PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
04:10PM  Investor Calendar Invites You to the Chembio Third Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, November 10, 2016 Accesswire
Nov-04-16 04:50PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:50AM  Chembio Agrees to Acquire Malaysia-based RVR Diagnostics and Establish Operations in Southeast Asia GlobeNewswire
Nov-02-16 04:34PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-01-16 08:50AM  Chembios DPP® Zika Test Approved by Brazils Health Regulatory Agency GlobeNewswire
Oct-31-16 08:50AM  Chembio to Host Conference Call to Discuss Third Quarter 2016 Financial Results GlobeNewswire
Oct-12-16 10:24AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-11-16 08:50AM  Chembio Expands Global Commercial Operations Leadership GlobeNewswire
Sep-28-16 03:03PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:50AM  Chembio Awarded CDC Contract for Zika, Dengue, and Chikungunya Surveillance Testing in India, Peru, Guatemala and Haiti GlobeNewswire
Sep-26-16 08:50AM  Chembio Awarded Grant from U.S. Department of Agriculture to Develop Point-of-Care Diagnostic Test for Bovine Tuberculosis GlobeNewswire
Sep-23-16 08:50AM  Chembio Expands Exclusive Distribution Agreements with Isla Lab to Include Puerto Rico and U.S. Virgin Islands GlobeNewswire
Sep-12-16 02:07PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
01:00PM  Chembio to Present Today at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Aug-25-16 11:47AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +14.94%
09:53AM  Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus GlobeNewswire
Aug-18-16 03:33PM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +5.93%
08:50AM  Chembio Expands Product Distribution through Exclusive Agreement with Isla Lab in the Caribbean GlobeNewswire
Aug-16-16 01:00PM  CEMI: Significant Growth Opportunity in Fever Accelerating Shift From STD -12.86%
Aug-12-16 11:22AM  Chembio Diagnostics, Inc. :CEMI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 08:50AM  Chembio Diagnostics Reports Second Quarter 2016 Financial Results GlobeNewswire
08:31AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:18AM  CHEMBIO DIAGNOSTICS, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q2 2016 Chembio Diagnostics Inc Earnings Release - Before Market Open
Aug-10-16 04:05PM  Investor Calendar Invites You to the Chembio Second Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, August 11, 2016 Accesswire -6.26%
Chembio Diagnostics, Inc., together with its subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The company's products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a DPP HIV-Syphilis multiplex test for the detection of antibodies to HIV and syphilis; and a test for the detection of Hepatitis-C. Chembio Diagnostics, Inc. sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with Concussion Science Group Division of Perseus Science Group LLC to develop a POC diagnostic test for traumatic brain injury; and collaboration with an international diagnostics company to develop a POC diagnostic test for a specific type of cancer. It also has a collaboration with AstraZeneca to develop a POC diagnostic test to detect an undisclosed biomarker. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldman Neil AEVP & Chief Financial OfficerFeb 13Buy6.7514,815100,00114,815Feb 13 02:40 PM
Klugewicz Sharon WPresident, AmericasAug 28Option Exercise4.459,44842,04416,448Aug 30 04:29 PM
Meller GaryDirectorJul 13Option Exercise3.4810,00034,800115,000Jul 17 03:01 PM
PESSIN NORMAN HSee Explanation of ResponsesJun 28Buy5.766,25035,9831,152,317Jun 29 04:26 PM